Business Wire

Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection, its First Product Compatible with Bluesight's KitCheck System

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a leading provider of injectable medications, announced today it has launched Rocuronium Bromide Injection with advanced RFID-enabled labels in the ...
FierceBiotech

Sagent Pharmaceuticals Announces Two New FDA Approvals: Sumatriptan Succinate Injection and Rocuronium Bromide Injection

SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...
The Barre-Montpelier Times Argus

Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...
Medscape

Neuromuscular Blockade-Reversal Choice Shows Shift Toward Rocuronium-Sugammadex Use in Patients With Renal Impairment

The use of rocuronium and sugammadex for reversing neuromuscular blockade increased dramatically over 6 years in patients with moderate and severe renal impairment. The variation in strategy selection ...